These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 10071767)

  • 1. Phosphorylation and recycling kinetics of G protein-coupled receptors.
    Innamorati G; Sadeghi H; Birnbaumer M
    J Recept Signal Transduct Res; 1999; 19(1-4):315-26. PubMed ID: 10071767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A serine cluster prevents recycling of the V2 vasopressin receptor.
    Innamorati G; Sadeghi HM; Tran NT; Birnbaumer M
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2222-6. PubMed ID: 9482866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonist-dependent phosphorylation of human muscarinic receptors in Spodoptera frugiperda insect cell membranes by G protein-coupled receptor kinases.
    Debburman SK; Kunapuli P; Benovic JL; Hosey MM
    Mol Pharmacol; 1995 Feb; 47(2):224-33. PubMed ID: 7870029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Charged residues of the conserved DRY triplet of the vasopressin V1a receptor provide molecular determinants for cell surface delivery and internalization.
    Hawtin SR
    Mol Pharmacol; 2005 Oct; 68(4):1172-82. PubMed ID: 16049168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of mechanism of desmopressin binding in vasopressin V2 receptor versus vasopressin V1a and oxytocin receptors: molecular dynamics simulation of the agonist-bound state in the membrane-aqueous system.
    Slusarz MJ; Slusarz R; Ciarkowski J
    Biopolymers; 2006 Apr; 81(5):321-38. PubMed ID: 16333859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long and the short cycle. Alternative intracellular routes for trafficking of G-protein-coupled receptors.
    Innamorati G; Le Gouill C; Balamotis M; Birnbaumer M
    J Biol Chem; 2001 Apr; 276(16):13096-103. PubMed ID: 11150299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice.
    Hiroyama M; Wang S; Aoyagi T; Oikawa R; Sanbe A; Takeo S; Tanoue A
    Eur J Pharmacol; 2007 Mar; 559(2-3):89-97. PubMed ID: 17275806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of interactions responsible for vasopressin binding to human neurohypophyseal hormone receptors-molecular dynamics study of the activated receptor-vasopressin-G(alpha) systems.
    Slusarz MJ; Giełdoń A; Slusarz R; Ciarkowski J
    J Pept Sci; 2006 Mar; 12(3):180-9. PubMed ID: 16114100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient phosphorylation of the V1a vasopressin receptor.
    Innamorati G; Sadeghi H; Birnbaumer M
    J Biol Chem; 1998 Mar; 273(12):7155-61. PubMed ID: 9507030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation, dephosphorylation, and recycling of the C5a receptor in differentiated HL60 cells.
    Giannini E; Boulay F
    J Immunol; 1995 Apr; 154(8):4055-64. PubMed ID: 7706744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desensitization of G protein-coupled receptors.
    Freedman NJ; Lefkowitz RJ
    Recent Prog Horm Res; 1996; 51():319-51; discussion 352-3. PubMed ID: 8701085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones.
    Cheong HI; Cho HY; Park HW; Ha IS; Choi Y
    Nephrology (Carlton); 2007 Apr; 12(2):113-7. PubMed ID: 17371330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arrestin effects on internalization of vasopressin receptors.
    Bowen-Pidgeon D; Innamorati G; Sadeghi HM; Birnbaumer M
    Mol Pharmacol; 2001 Jun; 59(6):1395-401. PubMed ID: 11353798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with beta-arrestin and their trafficking patterns.
    Terrillon S; Barberis C; Bouvier M
    Proc Natl Acad Sci U S A; 2004 Feb; 101(6):1548-53. PubMed ID: 14757828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of amino acid residues that direct differential ligand selectivity of mammalian and nonmammalian V1a type receptors for arginine vasopressin and vasotocin. Insights into molecular coevolution of V1a type receptors and their ligands.
    Acharjee S; Do-Rego JL; Oh DY; Ahn RS; Choe H; Vaudry H; Kim K; Seong JY; Kwon HB
    J Biol Chem; 2004 Dec; 279(52):54445-53. PubMed ID: 15475353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic interaction of human vasopressin/oxytocin receptor subtypes with G protein-coupled receptor kinases and protein kinase C after agonist stimulation.
    Berrada K; Plesnicher CL; Luo X; Thibonnier M
    J Biol Chem; 2000 Sep; 275(35):27229-37. PubMed ID: 10858434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for K268 in V2R folding.
    Gouill CL; Darden T; Madziva MT; Birnbaumer M
    FEBS Lett; 2005 Sep; 579(22):4985-90. PubMed ID: 16115624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of the V2 vasopressin receptor.
    Innamorati G; Sadeghi H; Eberle AN; Birnbaumer M
    J Biol Chem; 1997 Jan; 272(4):2486-92. PubMed ID: 8999963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Processing and ligand-induced modifications of the V2 vasopressin receptor.
    Sadeghi HM; Innamorati G; Esqueda E; Birnbaumer M
    Adv Exp Med Biol; 1998; 449():339-46. PubMed ID: 10026823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. O-Glycosylation of the V2 vasopressin receptor.
    Sadeghi H; Birnbaumer M
    Glycobiology; 1999 Jul; 9(7):731-7. PubMed ID: 10362843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.